DPYSL2 and heart failure: For instance, the delivery of siRNA targeting collapsin response mediator protein-2 (CRMP2) through lipidoid nanoparticles resulted in a drastic switch toward the anti-inflammatory macrophage phenotype which decreased inflammation, fibrosis, and heart failure postmyocardial infarction [128].